The Daily Pulse of Bursa Malaysia

Apex Healthcare on investors’ radar signalling higher share price momentum. How high can it go?

zaclim
Publish date: Tue, 02 Apr 2024, 08:25 AM
zaclim
0 101
Daily Pulse is a blog that provides daily stock updates and insights on the Bursa Malaysia.

Follow us in telegram for more daily discussion
https://t.me/xifuinvcommunity

Apex Healthcare Bhd has been gaining traction recently. The counter was on the top gainers’ list on April 1, up 3.4% to close at RM3.05. It is certainly no April’s Fool’s joke as the counter has been climbing despite being given stock downgrades by analysts.

On a year-to-date basis, the pharmaceutical company has risen 22% having touched a 52-week high of RM3.16 from a low of RM2.34 In February, it posted a record FY23 revenue with special dividend of 20 sen, which probably got investors excited.

However, analysts are less positive on Apex Healthcare. Apex’s 4QFY23 core earnings fell 40% on a YoY basis, despite posting a 9% revenue growth. It was dragged by several factors including lower contribution from 16%-owned Straits Apex as a result of reduced equity stake and higher amortisation expenses as well as higher tax expenses.

Straits Apex is an orthopaedic business, which Apex Healthcare pare its stake from 40% to 16% in May 2023. Even as Covid cases are on the rise, Xepa anticipates that demand for flu-related medication in 4QCY23 will not increase materially, possibly due to milder symptoms. As a result, revenue and earnings could be lower QoQ given demand for pharmaceutical products (especially flu-related medications) could experience moderation.

In FY24, Apex Healthcare is expected to register a 7% revenue growth albeit a flattish earnings growth following the lower effective equity stake in SA. Moving forward, Apex plans to submit applications to relevant authorities this year for the expansion of warehouses and liquid production facilities in a newly acquired 20.7-acre land.

However, the earnings contribution from this initiative may materialise only after 2025. After that, further upside will be supported by an organic expansion pipeline, given that the Cheng Industrial Estate production facility in Melaka is fully utilise

The stock is also likely to see higher FY23-25 earnings banking on Xepa-Soul Pattinson (Malaysia)’s (Xepa) long-term expansion plans. Xepa is involved in the development, manufacturing and marketing of off-patent/generic pharmaceutical products and medical devices. The Xepa campus is situated in Cheng Industrial Estate, Melaka, encompassing a 10-acre site.

Analysts anticipate Apex Healthcare’s FY26 earnings to register a 8.5% YoY growth, underpinned by an ageing population, public health education advancement and continuously expanding healthcare expenditure.

More articles on The Daily Pulse of Bursa Malaysia
InNature should trend higher despite poor results

Created by zaclim | May 30, 2024

It has been tough for InNature Bhd, having seen declining sales and margins. But the counter appears to be looking positive with an upward bias expected.

Time to shop at Parkson?

Created by zaclim | May 29, 2024

Parkson Holdings Bhd has been trending higher to close at a 3-month high recently. Does this signal better days for the department store operator?

Glomac flies high, going higher on stronger sales

Created by zaclim | May 27, 2024

Glomac Bhd has touched a multi-year high of 44 sen recently. It is likely to trend higher given its huge growth potential.

Evergreen maximising golden potential in pawnbroking and gold trading businesses

Created by zaclim | May 27, 2024

Evergreen Max Cash Capital Bhd has garnered much trading interest in the past month hitting a high to close at 48 sen recently. Can it surpass its high of 56 sen soon?

Aemulus may be in the red but draws investors’ interest

Created by zaclim | May 24, 2024

Aemulus Holdings Bhd posted its 6th losses in 2Q results recently. However, it is garnering investors attention as semiconductor industry takes a positive spin.

Bahvest trends higher as gold prices hit record high

Created by zaclim | May 23, 2024

ahvest Resources Bhd has been going on a good run, hitting a new high of 62 sen recently. Sustainably higher gold prices should drive investors to this counter.

Perdana Petroleum trades on new highs as it rides on come new jobs.

Created by zaclim | May 21, 2024

Perdana Petroleum is poised for further upside after touching its new high recently. It is a key beneficiary of an increase in upstream maintenance activities, drawing in plenty of trading activities.

MGB’s swelling order book anchors its forward earnings

Created by zaclim | May 20, 2024

MGB Bhd has been on the uptrend as it picks up contracts to ensure growth is sustainable. Its undemanding valuations should draw investors in.

Cengild may see a boost in share price after trading sideways since its listing

Created by zaclim | May 17, 2024

Cengild is on a downtrend since its listing in 2022 although it managed to touch a high of 46 sen in August 2023. But there seems to be more excitement for the counter as it rises from the oblivion.

MN Holdings holds on to recent highs but for how long?

Created by zaclim | May 14, 2024

MN Holdings Bhd has risen 134% in the past year to close at 74 sen on May 13. With exposure in the booming data centre and gree energy play, there could be further upside for the company

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment